- P2Y(12) inhibitor loading time before elective PCI and the prevention of myocardial necrosis2024 | Third Faculty of Medicine
- The mortality benefit seen with the newer more potent oral P2Y(12) inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis2018 | Third Faculty of Medicine
- A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study2011 | Third Faculty of Medicine
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention : Insights From the AUGUSTUS Trial2019 | First Faculty of Medicine
- Antiplatelet effect of prasugrel and clopidogrel in hypothermic patients after cardiac arrest for acute myocardial infarction2014 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study2020 | Third Faculty of Medicine
- Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis2019 | Publication without faculty affiliation